-
1
-
-
0037214260
-
Genetic basis of Fanconi anemia
-
Bagby GC Jr. Genetic basis of Fanconi anemia. Curr Opin Hematol. 2003; 10:68-76.
-
(2003)
Curr Opin Hematol
, vol.10
, pp. 68-76
-
-
Bagby, G.C.1
-
2
-
-
33744481750
-
Molecular pathogenesis of Fanconi anemia: recent progress
-
Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood. 2006; 107:4223-33. doi: 10.1182/blood-2005-10-4240.
-
(2006)
Blood
, vol.107
, pp. 4223-4233
-
-
Taniguchi, T.1
D'Andrea, A.D.2
-
3
-
-
33646196532
-
Regulation of DNA repair by ubiquitylation
-
Huang TT, D'Andrea AD. Regulation of DNA repair by ubiquitylation. Nat Rev Mol Cell Biol. 2006; 7:323-34. doi: 10.1038/nrm1908.
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, pp. 323-334
-
-
Huang, T.T.1
D'Andrea, A.D.2
-
4
-
-
21244452431
-
New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein
-
Fei P, Yin J, Wang W. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein. Cell Cycle. 2005; 4:80-6.
-
(2005)
Cell Cycle
, vol.4
, pp. 80-86
-
-
Fei, P.1
Yin, J.2
Wang, W.3
-
5
-
-
33645708319
-
Regulation of monoubiquitinated PCNA by DUB autocleavage
-
Huang TT, Nijman SM, Mirchandani KD, Galardy PJ, Cohn MA, Haas W, Gygi SP, Ploegh HL, Bernards R, D'Andrea AD. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol. 2006; 8:339-47. doi: 10.1038/ncb1378.
-
(2006)
Nat Cell Biol
, vol.8
, pp. 339-347
-
-
Huang, T.T.1
Nijman, S.M.2
Mirchandani, K.D.3
Galardy, P.J.4
Cohn, M.A.5
Haas, W.6
Gygi, S.P.7
Ploegh, H.L.8
Bernards, R.9
D'Andrea, A.D.10
-
7
-
-
0042161939
-
The Fanconi road to cancer
-
D'Andrea AD. The Fanconi road to cancer. Genes Dev. 2003; 17:1933-6. doi: 10.1101/gad.1128303.
-
(2003)
Genes Dev
, vol.17
, pp. 1933-1936
-
-
D'Andrea, A.D.1
-
8
-
-
0037268338
-
The Fanconi anaemia/BRCA pathway
-
D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003; 3:23-34. doi: 10.1038/nrc970.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 23-34
-
-
D'Andrea, A.D.1
Grompe, M.2
-
9
-
-
0037420026
-
BRCA2 germline mutations in familial pancreatic carcinoma
-
Hahn SA, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B, Gerdes B, Kress R, Ziegler A, Raeburn JA, Campra D, Grutzmann R, Rehder H, et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst. 2003; 95:214-21.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 214-221
-
-
Hahn, S.A.1
Greenhalf, B.2
Ellis, I.3
Sina-Frey, M.4
Rieder, H.5
Korte, B.6
Gerdes, B.7
Kress, R.8
Ziegler, A.9
Raeburn, J.A.10
Campra, D.11
Grutzmann, R.12
Rehder, H.13
-
10
-
-
25144449181
-
A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M
-
Meetei AR, Medhurst AL, Ling C, Xue Y, Singh TR, Bier P, Steltenpool J, Stone S, Dokal I, Mathew CG, Hoatlin M, Joenje H, de Winter JP, et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet. 2005; 37:958-63. doi: 10.1038/ng1626.
-
(2005)
Nat Genet
, vol.37
, pp. 958-963
-
-
Meetei, A.R.1
Medhurst, A.L.2
Ling, C.3
Xue, Y.4
Singh, T.R.5
Bier, P.6
Steltenpool, J.7
Stone, S.8
Dokal, I.9
Mathew, C.G.10
Hoatlin, M.11
Joenje, H.12
de Winter, J.P.13
-
11
-
-
33846569450
-
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
-
Reid S SD, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007; 39:162-4.
-
(2007)
Nat Genet
, vol.39
, pp. 162-164
-
-
Reid, S.S.D.1
Hanenberg, H.2
Barker, K.3
Hanks, S.4
Kalb, R.5
Neveling, K.6
Kelly, P.7
Seal, S.8
Freund, M.9
Wurm, M.10
Batish, S.D.11
Lach, F.P.12
Yetgin, S.13
-
12
-
-
2942628010
-
The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice
-
Roest HP, Baarends WM, de Wit J, van Klaveren JW, Wassenaar E, Hoogerbrugge JW, van Cappellen WA, Hoeijmakers JH, Grootegoed JA. The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice. Mol Cell Biol. 2004; 24:5485-95.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 5485-5495
-
-
Roest, H.P.1
Baarends, W.M.2
de Wit, J.3
van Klaveren, J.W.4
Wassenaar, E.5
Hoogerbrugge, J.W.6
van Cappellen, W.A.7
Hoeijmakers, J.H.8
Grootegoed, J.A.9
-
13
-
-
33846601829
-
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
-
Xia B DJ, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, de Winter JP. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet. 2007; 39:159-61.
-
(2007)
Nat Genet
, vol.39
, pp. 159-161
-
-
Xia, B.D.J.1
Ameziane, N.2
de Vries, Y.3
Rooimans, M.A.4
Sheng, Q.5
Pals, G.6
Errami, A.7
Gluckman, E.8
Llera, J.9
Wang, W.10
Livingston, D.M.11
Joenje, H.12
de Winter, J.P.13
-
14
-
-
34548759123
-
Emergence of a DNA-damage response network consisting of Fanconi aneamia and BRCA proteins
-
Wang W. Emergence of a DNA-damage response network consisting of Fanconi aneamia and BRCA proteins. Nature reviews Genetics. 2007; 8:735-48.
-
(2007)
Nature reviews Genetics
, vol.8
, pp. 735-748
-
-
Wang, W.1
-
15
-
-
79959635260
-
DNA interstrand crosslink repair and cancer
-
Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer. 2011; 11:467-80. doi: 10.1038/nrc3088.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 467-480
-
-
Deans, A.J.1
West, S.C.2
-
16
-
-
84877584276
-
Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia
-
Bogliolo M, Schuster B, Stoepker C, Derkunt B, Su Y, Raams A, Trujillo JP, Minguillon J, Ramirez MJ, Pujol R, Casado JA, Banos R, Rio P, et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet. 2013; 92:800-6. doi: 10.1016/j.ajhg.2013.04.002.
-
(2013)
Am J Hum Genet
, vol.92
, pp. 800-806
-
-
Bogliolo, M.1
Schuster, B.2
Stoepker, C.3
Derkunt, B.4
Su, Y.5
Raams, A.6
Trujillo, J.P.7
Minguillon, J.8
Ramirez, M.J.9
Pujol, R.10
Casado, J.A.11
Banos, R.12
Rio, P.13
-
17
-
-
84994391673
-
Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia
-
Mamrak NE, Shimamura A, Howlett NG. Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia. Blood Rev. 2016. doi: 10.1016/j.blre.2016.10.002.
-
(2016)
Blood Rev
-
-
Mamrak, N.E.1
Shimamura, A.2
Howlett, N.G.3
-
18
-
-
84969945397
-
Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene
-
Park JY, Virts EL, Jankowska A, Wiek C, Othman M, Chakraborty SC, Vance GH, Alkuraya FS, Hanenberg H, Andreassen PR. Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene. J Med Genet. 2016; 53:672-80. doi: 10.1136/jmedgenet-2016-103847.
-
(2016)
J Med Genet
, vol.53
, pp. 672-680
-
-
Park, J.Y.1
Virts, E.L.2
Jankowska, A.3
Wiek, C.4
Othman, M.5
Chakraborty, S.C.6
Vance, G.H.7
Alkuraya, F.S.8
Hanenberg, H.9
Andreassen, P.R.10
-
19
-
-
84987810005
-
Biallelic inactivation of REV7 is associated with Fanconi anemia
-
Bluteau D, Masliah-Planchon J, Clairmont C, Rousseau A, Ceccaldi R, Dubois d'Enghien C, Bluteau O, Cuccuini W, Gachet S, Peffault de Latour R, Leblanc T, Socie G, Baruchel A, et al. Biallelic inactivation of REV7 is associated with Fanconi anemia. J Clin Invest. 2016; 126:3580-4. doi: 10.1172/JCI88010.
-
(2016)
J Clin Invest
, vol.126
, pp. 3580-3584
-
-
Bluteau, D.1
Masliah-Planchon, J.2
Clairmont, C.3
Rousseau, A.4
Ceccaldi, R.5
Dubois d'Enghien, C.6
Bluteau, O.7
Cuccuini, W.8
Gachet, S.9
Peffault de Latour, R.10
Leblanc, T.11
Socie, G.12
Baruchel, A.13
-
20
-
-
0034331336
-
Arrest of S-phase progression is impaired in Fanconi anemia cells
-
Sala-Trepat M, Rouillard D, Escarceller M, Laquerbe A, Moustacchi E, Papadopoulo D. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp Cell Res. 2000; 260:208-15.
-
(2000)
Exp Cell Res
, vol.260
, pp. 208-215
-
-
Sala-Trepat, M.1
Rouillard, D.2
Escarceller, M.3
Laquerbe, A.4
Moustacchi, E.5
Papadopoulo, D.6
-
21
-
-
0141730414
-
FANCL, as in ligase
-
Grompe M. FANCL, as in ligase. Nature genetics. 2003; 35:113-4.
-
(2003)
Nature genetics
, vol.35
, pp. 113-114
-
-
Grompe, M.1
-
22
-
-
33846625493
-
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
-
Rahman N SS, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007; 39:165-7.
-
(2007)
Nat Genet
, vol.39
, pp. 165-167
-
-
Rahman, N.S.S.1
Thompson, D.2
Kelly, P.3
Renwick, A.4
Elliott, A.5
Reid, S.6
Spanova, K.7
Barfoot, R.8
Chagtai, T.9
Jayatilake, H.10
McGuffog, L.11
Hanks, S.12
Evans, D.G.13
-
23
-
-
0015043748
-
Mutation and cancer: statistical study of retinoblastoma
-
Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971; 68:820-3.
-
(1971)
Proc Natl Acad Sci U S A
, vol.68
, pp. 820-823
-
-
Knudson, A.G.1
-
24
-
-
0037248593
-
A conserved RING finger protein required for histone H2B monoubiquitination and cell size control
-
Hwang WW, Venkatasubrahmanyam S, Ianculescu AG, Tong A, Boone C, Madhani HD. A conserved RING finger protein required for histone H2B monoubiquitination and cell size control. Mol Cell. 2003; 11:261-6.
-
(2003)
Mol Cell
, vol.11
, pp. 261-266
-
-
Hwang, W.W.1
Venkatasubrahmanyam, S.2
Ianculescu, A.G.3
Tong, A.4
Boone, C.5
Madhani, H.D.6
-
25
-
-
25144457604
-
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
-
Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW, Elghalbzouri-Maghrani E, Steltenpool J, Rooimans MA, Pals G, Arwert F, Mathew CG, Zdzienicka MZ, et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet. 2005; 37:934-5.
-
(2005)
Nat Genet
, vol.37
, pp. 934-935
-
-
Levitus, M.1
Waisfisz, Q.2
Godthelp, B.C.3
de Vries, Y.4
Hussain, S.5
Wiegant, W.W.6
Elghalbzouri-Maghrani, E.7
Steltenpool, J.8
Rooimans, M.A.9
Pals, G.10
Arwert, F.11
Mathew, C.G.12
Zdzienicka, M.Z.13
-
26
-
-
0015216178
-
Fanconi's anaemia in the genetics of neoplasia
-
Swift M. Fanconi's anaemia in the genetics of neoplasia. Nature. 1971; 230:370-3.
-
(1971)
Nature
, vol.230
, pp. 370-373
-
-
Swift, M.1
-
27
-
-
34548759123
-
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
-
Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007; 8:735-48. doi: 10.1038/nrg2159.
-
(2007)
Nat Rev Genet
, vol.8
, pp. 735-748
-
-
Wang, W.1
-
28
-
-
18444362122
-
Biallelic inactivation of BRCA2 in Fanconi anemia
-
Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 2002; 297:606-9. doi: 10.1126/science.1073834.
-
(2002)
Science
, vol.297
, pp. 606-609
-
-
Howlett, N.G.1
Taniguchi, T.2
Olson, S.3
Cox, B.4
Waisfisz, Q.5
De Die-Smulders, C.6
Persky, N.7
Grompe, M.8
Joenje, H.9
Pals, G.10
Ikeda, H.11
Fox, E.A.12
D'Andrea, A.D.13
-
29
-
-
33745200945
-
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
-
Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell. 2006; 22:719-29.
-
(2006)
Mol Cell
, vol.22
, pp. 719-729
-
-
Xia, B.1
Sheng, Q.2
Nakanishi, K.3
Ohashi, A.4
Wu, J.5
Christ, N.6
Liu, X.7
Jasin, M.8
Couch, F.J.9
Livingston, D.M.10
-
30
-
-
24944575242
-
BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ
-
Litman R, Peng M, Jin Z, Zhang F, Zhang J, Powell S, Andreassen PR, Cantor SB. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell. 2005; 8:255-65.
-
(2005)
Cancer Cell
, vol.8
, pp. 255-265
-
-
Litman, R.1
Peng, M.2
Jin, Z.3
Zhang, F.4
Zhang, J.5
Powell, S.6
Andreassen, P.R.7
Cantor, S.B.8
-
31
-
-
85056033799
-
Fanconi Anemia Group D2 Protein Participates in Replication Origin Firing
-
Panneerselvam J, Shen Y, Che R, Fei P. Fanconi Anemia Group D2 Protein Participates in Replication Origin Firing. Chemotherapy (Los Angel). 2016; 5. doi: 10.4172/2167-7700.1000206.
-
(2016)
Chemotherapy (Los Angel)
, vol.5
-
-
Panneerselvam, J.1
Shen, Y.2
Che, R.3
Fei, P.4
-
32
-
-
84981710125
-
The USP1-UAF1 complex interacts with RAD51AP1 to promote homologous recombination repair
-
Cukras S, Lee E, Palumbo E, Benavidez P, Moldovan GL, Kee Y. The USP1-UAF1 complex interacts with RAD51AP1 to promote homologous recombination repair. Cell Cycle. 2016; 15:2636-46. doi: 10.1080/15384101.2016.1209613.
-
(2016)
Cell Cycle
, vol.15
, pp. 2636-2646
-
-
Cukras, S.1
Lee, E.2
Palumbo, E.3
Benavidez, P.4
Moldovan, G.L.5
Kee, Y.6
-
33
-
-
84979986178
-
Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway
-
Jang SW, Jung JK, Kim JM. Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway. Cell Cycle. 2016; 15:2336-45. doi: 10.1080/15384101.2016.1201621.
-
(2016)
Cell Cycle
, vol.15
, pp. 2336-2345
-
-
Jang, S.W.1
Jung, J.K.2
Kim, J.M.3
-
34
-
-
84874612000
-
Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage
-
Fu D, Dudimah FD, Zhang J, Pickering A, Paneerselvam J, Palrasu M, Wang H, Fei P. Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage. Cell Cycle. 2013; 12:803-9.
-
(2013)
Cell Cycle
, vol.12
, pp. 803-809
-
-
Fu, D.1
Dudimah, F.D.2
Zhang, J.3
Pickering, A.4
Paneerselvam, J.5
Palrasu, M.6
Wang, H.7
Fei, P.8
-
35
-
-
40549120933
-
FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways
-
Zhang J, Zhao D, Wang H, Lin CJ, Fei P. FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways. Cell Cycle. 2008; 7:407-13.
-
(2008)
Cell Cycle
, vol.7
, pp. 407-413
-
-
Zhang, J.1
Zhao, D.2
Wang, H.3
Lin, C.J.4
Fei, P.5
-
36
-
-
84945582553
-
Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9
-
Fidaleo M, Svetoni F, Volpe E, Minana B, Caporossi D, Paronetto MP. Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9. Oncotarget. 2015; 6:31740-57. doi: 10.18632/oncotarget.5033.
-
(2015)
Oncotarget
, vol.6
, pp. 31740-31757
-
-
Fidaleo, M.1
Svetoni, F.2
Volpe, E.3
Minana, B.4
Caporossi, D.5
Paronetto, M.P.6
-
37
-
-
84941199225
-
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
-
Xargay-Torrent S, Lopez-Guerra M, Rosich L, Montraveta A, Roldan J, Rodriguez V, Villamor N, Aymerich M, Lagisetti C, Webb TR, Lopez-Otin C, Campo E, Colomer D. The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia. Oncotarget. 2015; 6:22734-49. doi: 10.18632/oncotarget.4212.
-
(2015)
Oncotarget
, vol.6
, pp. 22734-22749
-
-
Xargay-Torrent, S.1
Lopez-Guerra, M.2
Rosich, L.3
Montraveta, A.4
Roldan, J.5
Rodriguez, V.6
Villamor, N.7
Aymerich, M.8
Lagisetti, C.9
Webb, T.R.10
Lopez-Otin, C.11
Campo, E.12
Colomer, D.13
-
38
-
-
84991311716
-
The 3'UTR signature defines a highly metastatic subgroup of triple-negative breast cancer
-
Wang L, Hu X, Wang P, Shao ZM. The 3'UTR signature defines a highly metastatic subgroup of triple-negative breast cancer. Oncotarget. 2016. doi: 10.18632/oncotarget.10975.
-
(2016)
Oncotarget
-
-
Wang, L.1
Hu, X.2
Wang, P.3
Shao, Z.M.4
-
39
-
-
0037155592
-
An mRNA surveillance mechanism that eliminates transcripts lacking termination codons
-
Frischmeyer PA, van Hoof A, O'Donnell K, Guerrerio AL, Parker R, Dietz HC. An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science. 2002; 295:2258-61. doi: 10.1126/science.1067338.
-
(2002)
Science
, vol.295
, pp. 2258-2261
-
-
Frischmeyer, P.A.1
van Hoof, A.2
O'Donnell, K.3
Guerrerio, A.L.4
Parker, R.5
Dietz, H.C.6
-
40
-
-
13744254695
-
A large-scale analysis of mRNA polyadenylation of human and mouse genes
-
Tian B, Hu J, Zhang H, Lutz CS. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 2005; 33:201-12. doi: 10.1093/nar/gki158.
-
(2005)
Nucleic Acids Res
, vol.33
, pp. 201-212
-
-
Tian, B.1
Hu, J.2
Zhang, H.3
Lutz, C.S.4
-
41
-
-
0030606286
-
The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation
-
Takagaki Y, Seipelt RL, Peterson ML, Manley JL. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell. 1996; 87:941-52.
-
(1996)
Cell
, vol.87
, pp. 941-952
-
-
Takagaki, Y.1
Seipelt, R.L.2
Peterson, M.L.3
Manley, J.L.4
-
42
-
-
84869765539
-
Alternative polyadenylation: new insights from global analyses
-
Shi Y. Alternative polyadenylation: new insights from global analyses. RNA. 2012; 18:2105-17. doi: 10.1261/rna.035899.112.
-
(2012)
RNA
, vol.18
, pp. 2105-2117
-
-
Shi, Y.1
-
43
-
-
0023990221
-
A functional mRNA polyadenylation signal is required for transcription termination by RNA polymerase II
-
Connelly S, Manley JL. A functional mRNA polyadenylation signal is required for transcription termination by RNA polymerase II. Genes Dev. 1988; 2: 440-52.
-
(1988)
Genes Dev
, vol.2
, pp. 440-452
-
-
Connelly, S.1
Manley, J.L.2
-
44
-
-
84893763336
-
Means to an end: mechanisms of alternative polyadenylation of messenger RNA precursors
-
Gruber AR, Martin G, Keller W, Zavolan M. Means to an end: mechanisms of alternative polyadenylation of messenger RNA precursors. Wiley Interdiscip Rev RNA. 2014; 5:183-96. doi: 10.1002/wrna.1206.
-
(2014)
Wiley Interdiscip Rev RNA
, vol.5
, pp. 183-196
-
-
Gruber, A.R.1
Martin, G.2
Keller, W.3
Zavolan, M.4
-
45
-
-
36849044583
-
ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy
-
Smith S, Su D, Rigault de la Longrais IA, Schwartz P, Puopolo M, Rutherford TJ, Mor G, Yu H, Katsaros D. ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy. J Clin Oncol. 2007; 25:5172-9. doi: 10.1200/JCO.2007.11.8547.
-
(2007)
J Clin Oncol
, vol.25
, pp. 5172-5179
-
-
Smith, S.1
Su, D.2
Rigault de la Longrais, I.A.3
Schwartz, P.4
Puopolo, M.5
Rutherford, T.J.6
Mor, G.7
Yu, H.8
Katsaros, D.9
-
46
-
-
35948993791
-
Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis
-
Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 2007; 67:10117-22. doi: 10.1158/0008-5472.CAN-07-2544.
-
(2007)
Cancer Res
, vol.67
, pp. 10117-10122
-
-
Lu, L.1
Katsaros, D.2
de la Longrais, I.A.3
Sochirca, O.4
Yu, H.5
-
47
-
-
67650931988
-
Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II
-
Lu L, Katsaros D, Shaverdashvili K, Qian B, Wu Y, de la Longrais IA, Preti M, Menato G, Yu H. Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur J Cancer. 2009; 45:2212-8. doi: 10.1016/j.ejca.2009.05.003.
-
(2009)
Eur J Cancer
, vol.45
, pp. 2212-2218
-
-
Lu, L.1
Katsaros, D.2
Shaverdashvili, K.3
Qian, B.4
Wu, Y.5
de la Longrais, I.A.6
Preti, M.7
Menato, G.8
Yu, H.9
-
48
-
-
77951826151
-
FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth
-
Zhang J, Zhao D, Park HK, Wang H, Dyer RB, Liu W, Klee GG, McNiven MA, Tindall DJ, Molina JR, Fei P. FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth. J Clin Invest. 2010; 120:1524-34. doi: 10.1172/JCI40908.
-
(2010)
J Clin Invest
, vol.120
, pp. 1524-1534
-
-
Zhang, J.1
Zhao, D.2
Park, H.K.3
Wang, H.4
Dyer, R.B.5
Liu, W.6
Klee, G.G.7
McNiven, M.A.8
Tindall, D.J.9
Molina, J.R.10
Fei, P.11
-
49
-
-
84864557092
-
FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer
-
Panneerselvam J, Park HK, Zhang J, Dudimah FD, Zhang P, Wang H, Fei P. FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer. Cell Cycle. 2012; 11:2947-55. doi: 10.4161/cc.21400.
-
(2012)
Cell Cycle
, vol.11
, pp. 2947-2955
-
-
Panneerselvam, J.1
Park, H.K.2
Zhang, J.3
Dudimah, F.D.4
Zhang, P.5
Wang, H.6
Fei, P.7
-
50
-
-
84963676494
-
Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway
-
Panneerselvam J, Xie G, Che R, Su M, Zhang J, Jia W, Fei P. Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway. J Proteome Res. 2016; 15:1333-41. doi: 10.1021/acs.jproteome.6b00076.
-
(2016)
J Proteome Res
, vol.15
, pp. 1333-1341
-
-
Panneerselvam, J.1
Xie, G.2
Che, R.3
Su, M.4
Zhang, J.5
Jia, W.6
Fei, P.7
-
51
-
-
84940203045
-
Mutated Fanconi anemia pathway in non-Fanconi anemia cancers
-
Shen Y, Lee YH, Panneerselvam J, Zhang J, Loo LW, Fei P. Mutated Fanconi anemia pathway in non-Fanconi anemia cancers. Oncotarget. 2015; 6:20396-403. doi: 10.18632/oncotarget.4056.
-
(2015)
Oncotarget
, vol.6
, pp. 20396-20403
-
-
Shen, Y.1
Lee, Y.H.2
Panneerselvam, J.3
Zhang, J.4
Loo, L.W.5
Fei, P.6
-
52
-
-
85017001342
-
Advances in the understanding of Fanconi Anemia Complementation Group D2 Protein (FANCD2) in human cancer
-
Shen Y, Zhang J, Yu H, Fei P. Advances in the understanding of Fanconi Anemia Complementation Group D2 Protein (FANCD2) in human cancer. Cancer Cell Microenviron. 2015; 2. doi: 10.14800/ccm.986.
-
(2015)
Cancer Cell Microenviron
, vol.2
-
-
Shen, Y.1
Zhang, J.2
Yu, H.3
Fei, P.4
-
53
-
-
84961215185
-
Premeltons in DNA
-
Sobell HM. Premeltons in DNA. J Struct Funct Genomics. 2016; 17:17-31. doi: 10.1007/s10969-016-9202-4.
-
(2016)
J Struct Funct Genomics
, vol.17
, pp. 17-31
-
-
Sobell, H.M.1
-
54
-
-
84962316223
-
NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms
-
Yang H, Das P, Yu Y, Mao W, Wang Y, Baggerly K, Wang Y, Marquez RT, Bedi A, Liu J, Fishman D, Lu Z, Bast RC Jr. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms. Oncotarget. 2016; 7:3018-32. doi: 10.18632/oncotarget.6576.
-
(2016)
Oncotarget
, vol.7
, pp. 3018-3032
-
-
Yang, H.1
Das, P.2
Yu, Y.3
Mao, W.4
Wang, Y.5
Baggerly, K.6
Wang, Y.7
Marquez, R.T.8
Bedi, A.9
Liu, J.10
Fishman, D.11
Lu, Z.12
Bast, R.C.13
-
55
-
-
84971607457
-
Regulation of androgen receptor splice variant AR3 by PCGEM1
-
Zhang Z, Zhou N, Huang J, Ho TT, Zhu Z, Qiu Z, Zhou X, Bai C, Wu F, Xu M, Mo YY. Regulation of androgen receptor splice variant AR3 by PCGEM1. Oncotarget. 2016; 7:15481-91. doi: 10.18632/oncotarget.7139.
-
(2016)
Oncotarget
, vol.7
, pp. 15481-15491
-
-
Zhang, Z.1
Zhou, N.2
Huang, J.3
Ho, T.T.4
Zhu, Z.5
Qiu, Z.6
Zhou, X.7
Bai, C.8
Wu, F.9
Xu, M.10
Mo, Y.Y.11
-
56
-
-
13944278808
-
Evolutionary conservation of a novel splice variant of the Cds1/CHK2 checkpoint kinase restricted to its regulatory domain
-
Lemaire M, Prime J, Ducommun B, Bugler B. Evolutionary conservation of a novel splice variant of the Cds1/CHK2 checkpoint kinase restricted to its regulatory domain. Cell Cycle. 2004; 3:1267-70. doi: 10.4161/cc.3.10.1154.
-
(2004)
Cell Cycle
, vol.3
, pp. 1267-1270
-
-
Lemaire, M.1
Prime, J.2
Ducommun, B.3
Bugler, B.4
-
57
-
-
84885186311
-
Eukaryotic mRNA decay: methodologies, pathways, and links to other stages of gene expression
-
Perez-Ortin JE, Alepuz P, Chavez S, Choder M. Eukaryotic mRNA decay: methodologies, pathways, and links to other stages of gene expression. J Mol Biol. 2013; 425:3750-75. doi: 10.1016/j.jmb.2013.02.029.
-
(2013)
J Mol Biol
, vol.425
, pp. 3750-3775
-
-
Perez-Ortin, J.E.1
Alepuz, P.2
Chavez, S.3
Choder, M.4
-
58
-
-
19944371176
-
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
-
Fei P, Wang W, Kim SH, Wang S, Burns TF, Sax JK, Buzzai M, Dicker DT, McKenna WG, Bernhard EJ, El-Deiry WS. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell. 2004; 6:597-609. doi: 10.1016/j.ccr.2004.10.012.
-
(2004)
Cancer Cell
, vol.6
, pp. 597-609
-
-
Fei, P.1
Wang, W.2
Kim, S.H.3
Wang, S.4
Burns, T.F.5
Sax, J.K.6
Buzzai, M.7
Dicker, D.T.8
McKenna, W.G.9
Bernhard, E.J.10
El-Deiry, W.S.11
|